IBB vs INDA
iShares Biotechnology ETF vs iShares MSCI India ETF
IBB$217.75
iShares Biotechnology ETF
NASDAQ biotech and pharmaceutical companies.
Expense: 0.44%Yield: 0.16%
INDA$51.52
iShares MSCI India ETF
Indian large- and mid-cap equities.
Expense: 0.61%Yield: 0.00%
Quick take
- • IBB has the lower expense ratio at 0.44% vs 0.61% for INDA.
- • IBB pays a higher dividend yield (0.16%).
Side-by-side metrics
| Metric | IBB | INDA |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.44% | 0.61% |
Dividend yield Trailing 12-month yield. | 0.16% | 0.00% |
AUM Assets under management — bigger funds are typically more liquid. | $11.50B | $5.84B |
YTD return | 30.22% | -4.88% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.60 | 0.61 |
P/E ratio | 25.48 | 23.08 |
Last price | $217.75 | $51.52 |
Inception | — | — |
Issuer | iShares | iShares |
IBB top holdings
Top holdings · IBB
| GILD | Gilead Sciences Inc | 8.94% |
| AMGN | Amgen Inc | 8.31% |
| VRTX | Vertex Pharmaceuticals Inc | 7.87% |
| REGN | Regeneron Pharmaceuticals Inc | 6.24% |
| MRNA | Moderna Inc | 5.49% |
| NTRA | Natera Inc | 3.78% |
| ARGX | argenx SE ADR | 3.36% |
| BIIB | Biogen Inc | 2.52% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.50% |
| ILMN | Illumina Inc | 2.41% |
Sector breakdown · IBB
Healthcare100.0%
INDA top holdings
Top holdings · INDA
| HDFCBANK.NS | HDFC Bank Ltd | 6.28% |
| ICICIBANK.NS | ICICI Bank Ltd | 5.91% |
| RELIANCE.NS | Reliance Industries Ltd | 5.32% |
| BHARTIARTL.NS | Bharti Airtel Ltd | 4.40% |
| INFY.NS | Infosys Ltd | 2.86% |
| AXISBANK.BO | Axis Bank Ltd | 2.24% |
| LT.NS | Larsen & Toubro Ltd | 2.07% |
| KOTAKBANK.NS | Kotak Mahindra Bank Ltd | 2.00% |
| M&M.NS | Mahindra & Mahindra Ltd | 1.96% |
Sector breakdown · INDA
Real Estate1.4%
Consumer Cyclical12.2%
Basic Materials8.0%
Consumer Defensive5.0%
Technology8.7%
Communication Services5.5%
Financial Services29.6%
Utilities4.2%
Industrials9.9%
Energy8.0%
Healthcare7.6%
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $11.5B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.16%. Its largest holding is Gilead Sciences Inc (GILD), which represents 8.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About INDA
INDA (iShares MSCI India ETF) is Indian large- and mid-cap equities. Managed by iShares, the fund carries $5.8B in assets under management, an expense ratio of 0.61%. Its largest holding is HDFC Bank Ltd (HDFCBANK.NS), which represents 6.3% of the portfolio. Real Estate is the fund's largest sector exposure at 1.4%.